HNR ACQUISITION CORP (HNRA) Stock Fundamental Analysis

NYSEARCA:HNRA • US40472A1025

1.19 USD
+0.08 (+7.21%)
At close: Sep 17, 2024
1.32 USD
+0.13 (+10.92%)
After Hours: 9/17/2024, 8:12:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to HNRA. HNRA was compared to 0 industry peers in the Unkown industry. HNRA may be in some trouble as it scores bad on both profitability and health. HNRA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year HNRA has reported negative net income.
  • HNRA had a negative operating cash flow in the past year.
HNRA Yearly Net Income VS EBIT VS OCF VS FCFHNRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA -0.66%
ROE -0.79%
ROIC N/A
ROA(3y)-1.65%
ROA(5y)N/A
ROE(3y)-4.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNRA Yearly ROA, ROE, ROICHNRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -2 -4 -6 -8 -10

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HNRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNRA Yearly Profit, Operating, Gross MarginsHNRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • HNRA has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for HNRA has been reduced compared to a year ago.
HNRA Yearly Shares OutstandingHNRA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2M 4M 6M 8M 10M
HNRA Yearly Total Debt VS Total AssetsHNRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

  • HNRA has an Altman-Z score of 0.01. This is a bad value and indicates that HNRA is not financially healthy and even has some risk of bankruptcy.
  • A Debt/Equity ratio of 0.04 indicates that HNRA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 0.01
ROIC/WACCN/A
WACCN/A
HNRA Yearly LT Debt VS Equity VS FCFHNRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 20M 40M 60M 80M

2.3 Liquidity

  • HNRA has a Current Ratio of 0.12. This is a bad value and indicates that HNRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.12 indicates that HNRA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
HNRA Yearly Current Assets VS Current LiabilitesHNRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 200K 400K 600K 800K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for HNRA have decreased strongly by -5946.61% in the last year.
EPS 1Y (TTM)-5946.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 115.22% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-126.86%
EPS Next 3Y160.73%
EPS Next 5Y115.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HNRA Yearly Revenue VS EstimatesHNRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 20M 40M 60M
HNRA Yearly EPS VS EstimatesHNRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HNRA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HNRA Price Earnings VS Forward Price EarningsHNRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HNRA Per share dataHNRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • HNRA's earnings are expected to grow with 160.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-126.86%
EPS Next 3Y160.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HNRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

HNR ACQUISITION CORP

NYSEARCA:HNRA (9/17/2024, 8:12:04 PM)

After market: 1.32 +0.13 (+10.92%)

1.19

+0.08 (+7.21%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-20
Earnings (Next)N/A
Inst Owners1.48%
Inst Owner Change-77.97%
Ins Owners48.26%
Ins Owner Change0%
Market Cap6.59M
Revenue(TTM)N/A
Net Income(TTM)-330.00K
Analysts82.86
Price Target6.12 (414.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.16
P/tB 0.16
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0
BVpS7.53
TBVpS7.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.66%
ROE -0.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.65%
ROA(5y)N/A
ROE(3y)-4.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 0.01
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5946.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2Y-126.86%
EPS Next 3Y160.73%
EPS Next 5Y115.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12948%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y117.45%
EBIT Next 5Y92.69%
FCF growth 1Y-1419.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1419.41%
OCF growth 3YN/A
OCF growth 5YN/A

HNR ACQUISITION CORP / HNRA FAQ

Can you provide the ChartMill fundamental rating for HNR ACQUISITION CORP?

ChartMill assigns a fundamental rating of 1 / 10 to HNRA.


What is the valuation status of HNR ACQUISITION CORP (HNRA) stock?

ChartMill assigns a valuation rating of 1 / 10 to HNR ACQUISITION CORP (HNRA). This can be considered as Overvalued.


What is the profitability of HNRA stock?

HNR ACQUISITION CORP (HNRA) has a profitability rating of 0 / 10.


Can you provide the financial health for HNRA stock?

The financial health rating of HNR ACQUISITION CORP (HNRA) is 1 / 10.